Cargando…

Bioactive compound C498-0670 alleviates LPS-induced sepsis via JAK/STAT and NFκB signaling pathways

The JAK/STAT and NFκB signaling pathways are two major inflammatory signaling pathways that are usually activated simultaneously in the body’s inflammatory response to bacterial or viral infections. Hyperactivation of these two prominent signaling pathways is associated with various immune-related d...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jing, Zhang, Xinxin, Zhou, Mingming, Lu, Peizhe, Xu, Yuting, Wu, Lihong, Zhang, Qianyue, Wu, Zhihua, Xu, Xiaoyu, Shi, Pengfei, Wei, Qingda, Li, Xiaoyu, Song, Qiaoling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140310/
https://www.ncbi.nlm.nih.gov/pubmed/37122731
http://dx.doi.org/10.3389/fimmu.2023.1132265
_version_ 1785033130104586240
author Xu, Jing
Zhang, Xinxin
Zhou, Mingming
Lu, Peizhe
Xu, Yuting
Wu, Lihong
Zhang, Qianyue
Wu, Zhihua
Xu, Xiaoyu
Shi, Pengfei
Wei, Qingda
Li, Xiaoyu
Song, Qiaoling
author_facet Xu, Jing
Zhang, Xinxin
Zhou, Mingming
Lu, Peizhe
Xu, Yuting
Wu, Lihong
Zhang, Qianyue
Wu, Zhihua
Xu, Xiaoyu
Shi, Pengfei
Wei, Qingda
Li, Xiaoyu
Song, Qiaoling
author_sort Xu, Jing
collection PubMed
description The JAK/STAT and NFκB signaling pathways are two major inflammatory signaling pathways that are usually activated simultaneously in the body’s inflammatory response to bacterial or viral infections. Hyperactivation of these two prominent signaling pathways is associated with various immune-related diseases and mortality, pointing to an urgent need for drug development targeting JAK/STAT and/or NFκB signaling. In this study, we screened 18,840 compounds using our well-established dual STAT-NFκB driven luciferase reporter based high-throughput screening system and identified a bioactive compound C498-0670, which inhibits both JAK/STAT and NFκB signaling. C498-0670 inhibits the activation of STATs and p-IKKα/β in both the immortalized cell lines and primary peritoneal macrophages, while suppressing the expression of LPS-induced inflammatory mediators in vitro. In addition, the overall anti-inflammatory effects of C498-0670 were investigated using transcriptome sequencing and bioinformatics approaches. C498-0670 was predicted to alleviate sepsis/septic shock by disease/function analysis using IPA software, which was further verified in the LPS-induced mouse sepsis model in vivo. C498 reduced LPS-induced liver and kidney damage, myeloid cell infiltration, and pro-inflammatory cytokine and chemokine production in vivo. Furthermore, the SPR-HPLC-MS-based target fishing approach was used to identify the putative drug targets, and the high affinities of JAK2 (JAK/STAT signaling), NFKBIA (NFκB signaling), and IL-1β, NLRP1b (inflammasome signaling) for C498-0670 were verified by molecular docking approach. These results suggest that C498-0670 can be used as a dual-target inhibitor of JAK/STAT and NFκB signaling pathways for the treatment of various inflammatory diseases, especially septic shock.
format Online
Article
Text
id pubmed-10140310
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101403102023-04-29 Bioactive compound C498-0670 alleviates LPS-induced sepsis via JAK/STAT and NFκB signaling pathways Xu, Jing Zhang, Xinxin Zhou, Mingming Lu, Peizhe Xu, Yuting Wu, Lihong Zhang, Qianyue Wu, Zhihua Xu, Xiaoyu Shi, Pengfei Wei, Qingda Li, Xiaoyu Song, Qiaoling Front Immunol Immunology The JAK/STAT and NFκB signaling pathways are two major inflammatory signaling pathways that are usually activated simultaneously in the body’s inflammatory response to bacterial or viral infections. Hyperactivation of these two prominent signaling pathways is associated with various immune-related diseases and mortality, pointing to an urgent need for drug development targeting JAK/STAT and/or NFκB signaling. In this study, we screened 18,840 compounds using our well-established dual STAT-NFκB driven luciferase reporter based high-throughput screening system and identified a bioactive compound C498-0670, which inhibits both JAK/STAT and NFκB signaling. C498-0670 inhibits the activation of STATs and p-IKKα/β in both the immortalized cell lines and primary peritoneal macrophages, while suppressing the expression of LPS-induced inflammatory mediators in vitro. In addition, the overall anti-inflammatory effects of C498-0670 were investigated using transcriptome sequencing and bioinformatics approaches. C498-0670 was predicted to alleviate sepsis/septic shock by disease/function analysis using IPA software, which was further verified in the LPS-induced mouse sepsis model in vivo. C498 reduced LPS-induced liver and kidney damage, myeloid cell infiltration, and pro-inflammatory cytokine and chemokine production in vivo. Furthermore, the SPR-HPLC-MS-based target fishing approach was used to identify the putative drug targets, and the high affinities of JAK2 (JAK/STAT signaling), NFKBIA (NFκB signaling), and IL-1β, NLRP1b (inflammasome signaling) for C498-0670 were verified by molecular docking approach. These results suggest that C498-0670 can be used as a dual-target inhibitor of JAK/STAT and NFκB signaling pathways for the treatment of various inflammatory diseases, especially septic shock. Frontiers Media S.A. 2023-04-14 /pmc/articles/PMC10140310/ /pubmed/37122731 http://dx.doi.org/10.3389/fimmu.2023.1132265 Text en Copyright © 2023 Xu, Zhang, Zhou, Lu, Xu, Wu, Zhang, Wu, Xu, Shi, Wei, Li and Song https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Xu, Jing
Zhang, Xinxin
Zhou, Mingming
Lu, Peizhe
Xu, Yuting
Wu, Lihong
Zhang, Qianyue
Wu, Zhihua
Xu, Xiaoyu
Shi, Pengfei
Wei, Qingda
Li, Xiaoyu
Song, Qiaoling
Bioactive compound C498-0670 alleviates LPS-induced sepsis via JAK/STAT and NFκB signaling pathways
title Bioactive compound C498-0670 alleviates LPS-induced sepsis via JAK/STAT and NFκB signaling pathways
title_full Bioactive compound C498-0670 alleviates LPS-induced sepsis via JAK/STAT and NFκB signaling pathways
title_fullStr Bioactive compound C498-0670 alleviates LPS-induced sepsis via JAK/STAT and NFκB signaling pathways
title_full_unstemmed Bioactive compound C498-0670 alleviates LPS-induced sepsis via JAK/STAT and NFκB signaling pathways
title_short Bioactive compound C498-0670 alleviates LPS-induced sepsis via JAK/STAT and NFκB signaling pathways
title_sort bioactive compound c498-0670 alleviates lps-induced sepsis via jak/stat and nfκb signaling pathways
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140310/
https://www.ncbi.nlm.nih.gov/pubmed/37122731
http://dx.doi.org/10.3389/fimmu.2023.1132265
work_keys_str_mv AT xujing bioactivecompoundc4980670alleviateslpsinducedsepsisviajakstatandnfkbsignalingpathways
AT zhangxinxin bioactivecompoundc4980670alleviateslpsinducedsepsisviajakstatandnfkbsignalingpathways
AT zhoumingming bioactivecompoundc4980670alleviateslpsinducedsepsisviajakstatandnfkbsignalingpathways
AT lupeizhe bioactivecompoundc4980670alleviateslpsinducedsepsisviajakstatandnfkbsignalingpathways
AT xuyuting bioactivecompoundc4980670alleviateslpsinducedsepsisviajakstatandnfkbsignalingpathways
AT wulihong bioactivecompoundc4980670alleviateslpsinducedsepsisviajakstatandnfkbsignalingpathways
AT zhangqianyue bioactivecompoundc4980670alleviateslpsinducedsepsisviajakstatandnfkbsignalingpathways
AT wuzhihua bioactivecompoundc4980670alleviateslpsinducedsepsisviajakstatandnfkbsignalingpathways
AT xuxiaoyu bioactivecompoundc4980670alleviateslpsinducedsepsisviajakstatandnfkbsignalingpathways
AT shipengfei bioactivecompoundc4980670alleviateslpsinducedsepsisviajakstatandnfkbsignalingpathways
AT weiqingda bioactivecompoundc4980670alleviateslpsinducedsepsisviajakstatandnfkbsignalingpathways
AT lixiaoyu bioactivecompoundc4980670alleviateslpsinducedsepsisviajakstatandnfkbsignalingpathways
AT songqiaoling bioactivecompoundc4980670alleviateslpsinducedsepsisviajakstatandnfkbsignalingpathways